5-FU |
5-Fluorouracil |
AHR |
Aryl hydrocarbon receptor |
AP-1 |
Activator protein-1 transcription factor |
BAD |
BCL2-associated agonist of cell death |
BAX |
BCL2-associated X |
BCL2 |
B-cell lymphoma 2 |
CDC2 |
Cyclin-dependent kinase 2 |
CDC25C |
Cell Division Cycle 25C |
CDK2 |
Cyclin D-dependent kinase 2 |
CDK4 |
Cyclin D-dependent kinase 4 |
CDKN1A |
Cyclin-dependent kinase inhibitor 1A |
Chk2 |
Checkpoint kinase 2 |
DNA |
Deoxyribonucleic Acid |
EGFR |
Epidermal growth factor receptor |
EMT |
Epithelial–mesenchymal transition |
FADD |
Fas-associated death domain |
GRADE |
Grading of Recommendations Assessment, Development, and Evaluation |
HIF |
Hypoxia-inducible factor |
JNK |
c-Jun N-terminal kinase |
KMP |
Kaempferol |
MAPK |
Mitogen-activated protein kinase |
MMPs |
Matrix metalloproteinases |
mRNA |
Messenger ribonucleic acid |
mTOR |
Mammalian target of rapamycin |
Nrf2 |
Nuclear factor erythroid 2-related factor 2 |
PKB |
Protein kinase B, also known as AKT |
ROS |
Reactive oxygen species |
Smad2 |
Mothers against decapentaplegic homolog 2 |
Smad4 |
Mothers against decapentaplegic homolog 4 |
STAT |
Signal transducer and activator of transcription |
TFEB |
Transcription factor EB |
TGF-β1 |
Transforming growth factor-β1 |
VEGF |
Vascular endothelial growth factor |